Growth Metrics

Eton Pharmaceuticals (ETON) Cash from Investing Activities (2020 - 2025)

Eton Pharmaceuticals' Cash from Investing Activities history spans 6 years, with the latest figure at -$49000.0 for Q4 2025.

  • On a quarterly basis, Cash from Investing Activities rose 99.87% to -$49000.0 in Q4 2025 year-over-year; TTM through Dec 2025 was -$333000.0, a 99.17% increase, with the full-year FY2025 number at -$333000.0, up 99.17% from a year prior.
  • Cash from Investing Activities hit -$49000.0 in Q4 2025 for Eton Pharmaceuticals, up from -$284000.0 in the prior quarter.
  • Over the last five years, Cash from Investing Activities for ETON hit a ceiling of -$2000.0 in Q3 2021 and a floor of -$38.1 million in Q4 2024.
  • Historically, Cash from Investing Activities has averaged -$4.3 million across 5 years, with a median of -$761000.0 in 2022.
  • Biggest five-year swings in Cash from Investing Activities: plummeted 99900.0% in 2022 and later soared 99.87% in 2025.
  • Tracing ETON's Cash from Investing Activities over 5 years: stood at -$3.3 million in 2021, then soared by 99.63% to -$12000.0 in 2022, then plummeted by 6358.33% to -$775000.0 in 2023, then crashed by 4820.26% to -$38.1 million in 2024, then skyrocketed by 99.87% to -$49000.0 in 2025.
  • Business Quant data shows Cash from Investing Activities for ETON at -$49000.0 in Q4 2025, -$284000.0 in Q3 2025, and -$38.1 million in Q4 2024.